Daiichi Sankyo Pharma settles whistleblower case of doc kickbacks for $39 million

International pharma giant Daiichi Sankyo which started in Japan has agreed to pay Uncle Same over $39 million for allegations of kickbacks paid to doctors to use its pharmaceuticals. That is illegal under U.S. laws.

A False Claims whistleblower case was brought in March 2010 by  Kathy Fragoules, a former Daiichi Sankyo sales representative, who revealed in allegations that Daiichi Sankyo had various programs used by its sales representatives to induce physicians to use its pharmaceuticals, including Welchol, Azor, Benicar, and Benicar HCT. According to the complaint, these inducements caused physicians to prescribe Daiichi Sankyo pharmaceuticals for government healthcare program beneficiaries in violation of the Anti-Kickback Statute.

Jeffrey Newman represents whistleblowers but did not represent Ms. Fragoules.